Idea principal
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
Study design
Metaanálisis observacional
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Step counts are now easy to record, and the evidence linking them to health has grown quickly over the past decade. Existing systematic reviews, however, mostly looked at a few outcomes, such as all-cause mortality. The authors set out to bring together the prospective evidence on device-measured daily steps and a much wider set of outcomes in adults: all-cause mortality, cardiovascular disease, cancer, type 2 diabetes, cognitive outcomes, mental health outcomes, physical function and falls. They asked how risk changes across the range of daily steps, and where the curve levels off.
Población y método
This was a systematic review and dose-response meta-analysis, registered with PROSPERO. The authors searched PubMed and EBSCO CINAHL for literature published between 1 January 2014 and 14 February 2025, supplemented by other search strategies, and included prospective studies of adults that examined device-measured daily steps and health outcomes, with no restriction on language or publication type. Pairs of reviewers independently did study selection, data extraction and risk-of-bias assessment using the 9-point Newcastle-Ottawa Scale. In all, 57 studies from 35 cohorts went into the systematic review, and 31 studies from 24 cohorts into the meta-analyses. The abstract does not report participant ages, countries, devices or follow-up lengths, so full details are not available here.
Hazard ratios from individual studies were combined with random-effects dose-response meta-analysis where possible, and the main contrast was 7000 steps a day against 2000. Certainty of evidence was graded with GRADE. Heterogeneity between studies was summarised with I2, and physical function was described without meta-analysis. The abstract does not describe the dose-response modelling method or any sensitivity analyses.
Resultados
- 1More steps were associated with lower all-cause mortality, in a curve that bends. Compared with 2000 steps a day, 7000 steps had a hazard ratio of 0.53 (95% CI 0.46 to 0.60; 14 studies; I2 36.3), which the authors express as a 47% lower risk. The relationship was non-linear, with an inflection point at around 5000 to 7000 steps a day, and the certainty of evidence was moderate.
- 2Heart and brain outcomes also pointed the same way. For cardiovascular disease incidence the hazard ratio was 0.75 (0.67 to 0.85; six studies), for cardiovascular disease mortality 0.53 (0.37 to 0.77; three studies; low certainty) and for dementia 0.62 (0.53 to 0.73; two studies). Cardiovascular disease incidence and dementia curved with an inflection at around 5000 to 7000 steps a day, whereas cardiovascular disease mortality was linear.
- 3Cancer results differed by type of outcome. Cancer mortality had a hazard ratio of 0.63 (0.55 to 0.72; three studies), but cancer incidence had 0.94 (0.87 to 1.01; two studies), a non-significant 6% lower risk, with low certainty. Both followed linear associations.
- 4Type 2 diabetes, depressive symptoms and falls also showed lower risk at 7000 steps. The hazard ratio was 0.86 (0.74 to 0.99; four studies) for type 2 diabetes, 0.78 (0.73 to 0.83; three studies) for depressive symptoms and 0.72 (0.65 to 0.81; four studies) for falls. Type 2 diabetes and depressive symptoms were linear; falls curved with an inflection at around 5000 to 7000 steps a day, and certainty for falls was very low.
- 5Physical function was not pooled, but studies reported similar inverse associations, with low certainty. Certainty of evidence was moderate for all outcomes except cardiovascular disease mortality (low), cancer incidence (low), physical function (low) and falls (very low).
Límites e incertidumbre
- 1The authors note the small number of studies available for most outcomes. Dementia and cancer incidence each rest on two studies, and cardiovascular disease mortality, cancer mortality and depressive symptoms on three, so those estimates can shift with one new study.
- 2The authors note a lack of age-specific analysis, and biases at the level of individual studies, including residual confounding. In an observational set of cohorts, people who walk more also tend to be healthier in other ways.
- 3In our reading, heterogeneity was substantial for some outcomes (I2 78.2% for cardiovascular disease mortality, 73.7% for cancer incidence and 64.5% for cancer mortality), so the pooled estimates average over studies that disagree to a meaningful degree.
- 4In our reading, all the contrasts compare 7000 steps with a low reference of 2000 steps a day, and the percentages are relative reductions in hazard rather than absolute risk differences, so they say little about how much any one person's risk changes.
- 5This reading is based on the abstract only, which does not give participants' ages, countries, devices or follow-up lengths.
Relevancia práctica
These results support the idea that a daily count well below 10,000 steps is already associated with better health: 7000 steps was associated with lower risk across mortality, heart disease, dementia, type 2 diabetes, depressive symptoms and falls compared with 2000. The authors say 10,000 steps can still be a viable target for more active people but that 7000 may be a more realistic goal for some. The curves for several outcomes bend at around 5000 to 7000 steps a day, so the first increases from a low base are where the association is steepest.
The figures should not be read as a promise that walking 7000 steps will cut your own risk by the percentages shown, or as a threshold below which health is lost. Some outcomes, such as cancer incidence and falls, rest on few studies and low or very low certainty. The studies are observational, so steps may partly mark general health. Anyone managing a medical condition should set activity goals with their clinician.
Tus datos
Use the weekly average of your daily steps from one device, and compare it over several weeks rather than judging single days. The reference of 2000 steps a day is low, so the most useful comparison is your own recent average against a modest step up, not a distant target. The abstract does not say which devices were used, and step counts vary between phones, wrist devices and hip-worn counters, so keep the same device and wear habits. Illness, travel and days without the device will pull the average down.
Cómo interpretar la evidencia
Pooling observational studies does not remove their confounding. Check overlapping cohorts and whether relative effects are being confused with absolute benefits.
Fuentes y atribución
Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis
The Lancet Public Health · 2025-07-23
DOI: 10.1016/S2468-2667(25)00164-1 ↗PubMed · 40713949 ↗Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ
Older women who took more steps died less often, with gains levelling near 7,500 a day
Among 16,741 US women with a mean age of 72.0 years, mortality was lower in every higher step quartile than in the lowest (median 2,718 steps a day): hazard ratios were 0.59, 0.54 and 0.42 for medians of 4,363, 5,905 and 8,442. Mortality stopped falling at about 7,500 steps a day, and once total steps were accounted for, stepping intensity showed no significant link in the main comparisons. This is an observational study with a mean follow-up of 4.3 years, so it shows an association, not that walking more extends life.
JAMA Internal Medicine

